Chronic administration of azidothymidine (AZT) to patients with AIDS leads to pharmacological ineffectiveness of the drug. This phenomenon can occur both by changes in the T-lymphocyte host cell and the HIV virus. Clinical results from chronic administration of AZT in pediatric patients with AIDS indicate that the anti-HIV effectiveness of the pro-drug AZT is significantly decreased after 4 to 6 months of treatment. The peripheral blood lymphocytes (PBL) from seven pediatric AIDS patients being treated with AZT for up to 25 months were examined for their ability to phosphorylate [3H]AZT to [3H]AZTTP ex vivo. After 3 or more months of AZT therapy the formation of the monophosphate anabolite of AZT, AZTMP by PBL remained unchanged, whereas the cellular concentrations of the diphosphate anabolite, AZTDP, were reduced to 1/5 of controls. The AZTTP cellular concentrations were similarly reduced to 18% of control values. The data indicate that the decreased activation of AZT in vivo is primarily due to a decreased synthesis of AZTDP from AZTMP, a reaction catalyzed by thymidylate kinase (dTMP kinase). The scope of this proposal is to better define this mechanism of AZT resistance by experiments to: 1a) Determine the frequency over time of decreased AZT or other nucleoside analog drug activation in peripheral blood lymphocytes (PBL) from patients treated chronically with AZT alone or with AZT alone or with AZT in combination with dideoxyinosine (ddI). 1b) Determine by co-culture whether the resistance is caused by alteration in AZT sensitivity or other anti-HIV drug of the patients HIV-reverse transcriptase (RT).2) Determine the recently cloned human DTMP kinase expression in lymphocytes from these patients, which will affect the anabolism of both AZT and d4T. 3) Correlate DTMP kinase expression and sensitivity of PBL's to AZT or d4T. 4) Examine the mechanisms of cellular anabolism of nucleoside analog drugs in human T- cells.

Project Start
1997-01-01
Project End
1997-12-31
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Kempen, John H; Sugar, Elizabeth A; Varma, Rohit et al. (2014) Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections. Ophthalmology 121:2317-24
Kozak, Igor; Vaidya, Vijay; Van Natta, Mark L et al. (2014) The prevalence and incidence of epiretinal membranes in eyes with inactive extramacular CMV retinitis. Invest Ophthalmol Vis Sci 55:4304-12
Jabs, Douglas A; Ahuja, Alka; Van Natta, Mark et al. (2013) Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 120:1262-70
Wohl, David A; Kendall, Michelle A; Feinberg, Judith et al. (2013) The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit. PLoS One 8:e78676
Gangaputra, Sapna; Drye, Lea; Vaidya, Vijay et al. (2013) Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 155:206-212.e5
Ribaudo, Heather J; Smith, Kimberly Y; Robbins, Gregory K et al. (2013) Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis. Clin Infect Dis 57:1607-17
Kempen, John H; Sugar, Elizabeth A; Lyon, Alice T et al. (2012) Risk of cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome. Ophthalmology 119:2343-50
Gangaputra, Sapna; Kalyani, Partho S; Fawzi, Amani A et al. (2012) Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality. Am J Ophthalmol 153:434-444.e1
Kalyani, Partho S; Fawzi, Amani A; Gangaputra, Sapna et al. (2012) Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with visual function. Am J Ophthalmol 153:428-433.e1
Kalyani, Partho S; Holland, Gary N; Fawzi, Amani A et al. (2012) Association between retinal nerve fiber layer thickness and abnormalities of vision in people with human immunodeficiency virus infection. Am J Ophthalmol 153:734-42, 742.e1

Showing the most recent 10 out of 126 publications